-+ 0.00%
-+ 0.00%
-+ 0.00%

Axon Enterprise (AXON) Could Be 17% Undervalued As Board Adds AI And Enterprise Expertise

Simply Wall St·07/25/2026 23:17:26
語音播報

Axon Enterprise (AXON) has drawn fresh investor attention after appointing former Dell executive Vivek Mohindra and AI entrepreneur Eiso Kant as independent directors, in a board expansion closely tied to its public safety technology focus.

See our latest analysis for Axon Enterprise.

Axon Enterprise’s share price has climbed 9.99% over the past month and 26.50% over the past quarter to US$502.34, while its year to date share price return is down 10.85% and its 1 year total shareholder return has fallen 31.66%. This contrasts with a 3 year total shareholder return of 175.04%, suggesting longer term holders have seen strong gains even as recent momentum has cooled.

If this board refresh has you thinking more broadly about where AI hardware and software meet real world demand, it could be worth scanning opportunities in 55 AI infrastructure stocks

Axon Enterprise looks like a solid public safety platform business, backed by fresh AI expertise on its board, but at around US$502 a share, does that quality still come at a reasonable price today?

Most Popular Narrative: 17.2% Undervalued

Axon Enterprise’s most followed narrative puts fair value at $606.83 a share versus the last close at $502.34. This frames the stock as trading below that narrative estimate while investors reassess recent share price weakness and the longer term software story.

One company I find particularly interesting is Axon Enterprise. Many investors still associate the company primarily with TASER devices, but I think the more compelling part of the story is how Axon has quietly transformed itself into a software and data platform for public safety. What began as a hardware business is increasingly becoming an ecosystem built around digital evidence, cloud software, and connected policing tools.

Read the complete narrative.

The fair value hinges on Axon Enterprise being seen less as a device supplier and more as a sticky software platform. It leans heavily on recurring revenue, expanding digital evidence workflows and expectations around future profitability that look closer to software peers than traditional hardware. The important piece is how those moving parts are modelled together.

Result: Fair Value of $606.83 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Axon Enterprise’s story could be challenged if public safety budgets tighten or if rival platforms win major contracts and slow the adoption of its software.

Find out about the key risks to this Axon Enterprise narrative.

Another View: Our DCF Model Sees Axon Enterprise Differently

While the most popular Axon Enterprise narrative points to fair value of $606.83, our DCF model suggests a lower figure of $428.59 per share. In that view, the current $502.34 price screens as overvalued, raising questions about how much of the public safety software story is already priced in.

Look into how the SWS DCF model arrives at its fair value.

AXON Discounted Cash Flow as at Jul 2026
AXON Discounted Cash Flow as at Jul 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Axon Enterprise for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 49 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the split views on Axon Enterprise have you unsure what to make of the story, treat that as your cue to move quickly and check the underlying data yourself so you can decide how the balance of risks and rewards really looks. A good place to start is by weighing the 1 key reward and 3 important warning signs

Looking for more investment ideas beyond Axon Enterprise?

If Axon Enterprise has sharpened your focus on quality, do not stop here. Use the Simply Wall Street Screener to uncover other opportunities that might suit your approach.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.